Literature DB >> 8683941

Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes.

Y Saiki1, H Ohtani, Y Naito, M Miyazawa, H Nagura.   

Abstract

A subset of gastric carcinoma carries Epstein-Barr virus (EBV). The immunophenotypic features of EBV-associated (EBV+) gastric carcinoma, which we have analyzed using 25 EBV+ cases, remain unclear. Frozen tissue samples were stained with antibodies to various immune cell markers. To evaluate the proliferative activity of CD8+ cells, we performed CD8/Ki-67 double staining on paraffin-embedded sections. The results were compared with those in EBV-negative (EBV-) gastric carcinomas. All EBV+ and EBV- gastric carcinoma cells expressed major histocompatibility complex class I, whereas major histocompatibility complex class II expression in tumor cells was more prominent in EBV+ cases. Intercellular adhesion molecule-1 and Fas/APO-1 expression was largely restricted to EBV+ cases. The lymphocytes that infiltrated EBV+ tumor nests were predominantly CD8+ T cells, many of which expressed perforin. Immunoelectron microscopy confirmed a close cell to cell contact between these CD8+ cells and carcinoma cells. CD8+ cells were CD11a+ and CD11b- by flow cytometry performed in one case. The labeling index of Ki-67, the proliferation-associated antigen, in CD8+ cells was 4 times higher in EBV+ cases than in EBV- cases. Our data suggest that these CD8+ cells, which bear a cytotoxic phenotype, are actively proliferating in close contact with EBV+ tumor cells and that the specificity of the CD8+ cells may be directed to EBV and/or cellular antigens expressed by the tumor. This is consistent with a generally favorable prognosis of EBV+ gastric carcinoma. Because the observed T-cell infiltration is insufficient to eradicate the tumor cells, certain immunosuppressive factors were speculated to allow the essentially immunogenic carcinoma cells to establish a macroscopic lesion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683941

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  34 in total

Review 1.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

2.  Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.

Authors:  Yoshio Jinno; Haruo Ohtani; Shiro Nakamura; Motoji Oki; Kiyoshi Maeda; Kohei Fukushima; Hiroshi Nagura; Nobuhide Oshitani; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Virchows Arch       Date:  2006-01-25       Impact factor: 4.064

3.  In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis.

Authors:  Hiroyuki Abe; Teppei Morikawa; Ruri Saito; Hiroharu Yamashita; Yasuyuki Seto; Masashi Fukayama
Journal:  Virchows Arch       Date:  2016-02-25       Impact factor: 4.064

4.  Immunological activation of dermal Langerhans cells in contact with lymphocytes in a model of human inflamed skin.

Authors:  F Katou; H Ohtani; A Saaristo; H Nagura; K Motegi
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.

Authors:  M Constanza Camargo; Woo-Ho Kim; Anna Maria Chiaravalli; Kyoung-Mee Kim; Alejandro H Corvalan; Keitaro Matsuo; Jun Yu; Joseph J Y Sung; Roberto Herrera-Goepfert; Fernando Meneses-Gonzalez; Yuko Kijima; Shoji Natsugoe; Linda M Liao; Jolanta Lissowska; Sung Kim; Nan Hu; Carlos A Gonzalez; Yashushi Yatabe; Chihaya Koriyama; Stephen M Hewitt; Suminori Akiba; Margaret L Gulley; Philip R Taylor; Charles S Rabkin
Journal:  Gut       Date:  2013-04-12       Impact factor: 23.059

6.  Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.

Authors:  Ji Hye Park; Eun Kyung Kim; Yon Hee Kim; Jie-Hyun Kim; Yoon Sung Bae; Yong Chan Lee; Jae-Ho Cheong; Sung Hoon Noh; Hyunki Kim
Journal:  Gastric Cancer       Date:  2015-11-16       Impact factor: 7.370

7.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.

Authors:  Hiroshi Uozaki; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis.

Authors:  Enrico Solcia; Catherine Klersy; Luca Mastracci; Paola Alberizzi; Maria Elena Candusso; Marta Diegoli; Francesca Tava; Roberta Riboni; Rachele Manca; Ombretta Luinetti
Journal:  Virchows Arch       Date:  2009-08-12       Impact factor: 4.064

9.  Lymphoepithelioma-like carcinoma of the bladder: three cases with clinicopathological and p53 protein expression study.

Authors:  Francisco Miguel Izquierdo-García; Fructuoso García-Díez; Isabel Fernández; Alberto Pérez-Rosado; Anabel Sáez; Dimas Suárez-Vilela; Rafael Guerreiro-González; Manuel Benéitez-Alvarez
Journal:  Virchows Arch       Date:  2004-04-06       Impact factor: 4.064

10.  Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.

Authors:  Byung-Hoon Min; Chung Hyun Tae; Soo Min Ahn; So Young Kang; Sook-Young Woo; Seonwoo Kim; Kyoung-Mee Kim
Journal:  Gastric Cancer       Date:  2015-08-12       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.